Jeroen J. Eikenboom

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 190 publications

Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy.

Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy.

Journal: Thrombosis research

Published: April 05, 2026

Evaluation of patient experiences with a structured home treatment pathway for pulmonary embolism using direct oral anticoagulants.

Evaluation of patient experiences with a structured home treatment pathway for pulmonary embolism using direct oral anticoagulants.

Journal: Thrombosis research

Published: February 25, 2026

Plasma protein profile in patients with antiphospholipid syndrome and controls without APS.

Plasma protein profile in patients with antiphospholipid syndrome and controls without APS.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 30, 2026

Clinical and laboratory diagnosis of von Willebrand disease.

Clinical and laboratory diagnosis of von Willebrand disease.

Journal: Haematologica

Published: December 11, 2025

Implications of 2023 ACR/EULAR classification criteria for antiphospholipid syndrome and current diagnostic and therapeutic insights: A Delphi consensus.

Implications of 2023 ACR/EULAR classification criteria for antiphospholipid syndrome and current diagnostic and therapeutic insights: A Delphi consensus.

Journal: The American journal of medicine

Published: December 01, 2025

Thrombotic recurrence after anticoagulation cessation in patients with antiphospholipid syndrome and antiphospholipid antibody negativization: a systematic review and meta-analysis.

Thrombotic recurrence after anticoagulation cessation in patients with antiphospholipid syndrome and antiphospholipid antibody negativization: a systematic review and meta-analysis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 29, 2025

Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid Syndrome.

Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid Syndrome.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: October 24, 2025

Allele-selective von Willebrand factor silencing.

Allele-selective von Willebrand factor silencing.

Journal: Research and practice in thrombosis and haemostasis

Published: October 24, 2025

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.

Journal: Blood advances

Published: October 15, 2025

Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease.

Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease.

Journal: Frontiers in genome editing

Published: October 06, 2025

Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A.

Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A.

Journal: Research and practice in thrombosis and haemostasis

Published: September 30, 2025

Impact of a multidisciplinary clinical pathway on the management of spontaneous coronary artery dissection.

Impact of a multidisciplinary clinical pathway on the management of spontaneous coronary artery dissection.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: September 23, 2025

Showing 1-12 of 190

Last Updated: 09/26/2026